Efficient delivery and stable gene expression in a hematopoietic cell line using a chimeric serotype 35 fiber pseudotyped helper-dependent adenoviral vector

Virology

Volumn 324, Issue 1, 2004, Pages 229-237

  Balamotis, Michael Andrew ^a   Huang, Katie ^a   Mitani, Kohnosuke ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenoviral vector; Chimeric fiber; Helper dependent; Hematopoietic; K562; Quantitative real time PCR (QRT PCR); Silencing; Viral genome

Indexed keywords

ADENOVIRUS VECTOR; RECOMBINANT PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FIBER; GENE DELETION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEROTYPE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS RECOMBINANT;

ADENOVIRUSES, HUMAN; CELLS, CULTURED; GENE EXPRESSION; GENE SILENCING; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELPER VIRUSES; HUMANS; K562 CELLS; LUMINESCENT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSGENES;

ADENOVIRIDAE; COXSACKIEVIRUS; HUMAN ADENOVIRUS;

EID: 2942620322     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.03.030     Document Type: Article

References (46)

1. Arnberg N., Pring-Akerblom P., Wadell G. Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells. J. Virol. 76:2002;8834-8841
2. Barnett B.G., Crews C.J., Douglas J.T. Targeted adenoviral vectors. Biochim. Biophys. Acta. 1575:2002;1-14
3. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., Finberg R.W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 275:1997;1320-1323
4. Boulis N.M., Turner D.E., Imperiale M.J., Feldman E.L. Neuronal survival following remote adenovirus gene delivery. J. Neurosurg. 96:2002;212-219
5. Chalfie M., Tu Y., Euskirchen G., Ward W.W., Prasher D.C. Green fluorescent protein as a marker for gene expression. Science. 263:1994;802-805
6. Chen W.Y., Townes T.M. Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation. Proc. Natl. Acad. Sci. U.S.A. 97:2000;377-382
7. Chen W.Y., Bailey E.C., McCune S.L., Dong J.Y., Townes T.M. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc. Natl. Acad. Sci. U.S.A. 94:1997;5798-5803
8. Chen H.H., Mack L.M., Choi S.Y., Ontell M., Kochanek S., Clemens P.R. DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle. Hum. Gene Ther. 10:1999;365-373
9. Chillon M., Bosch A., Zabner J., Law L., Armentano D., Welsh M.J., Davidson B.L. Group D adenoviruses infect primary central nervous system cells more efficiently than those from group C. J. Virol. 73:1999;2537-2540
10. Cregan S.P., MacLaurin J., Gendron T.F., Callaghan S.M., Park D.S., Parks R.J., Graham F.L., Morley P., Slack R.S. Helper-dependent adenovirus vectors: their use as a gene delivery system to neurons. Gene Ther. 7:2000;1200-1209
11. Croyle M.A., Chirmule N., Zhang Y., Wilson J.M. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J. Virol. 75:2001;4792-4801
12. Devaux C., Caillet-Boudin M.L., Jacrot B., Boulanger P. Crystallization, enzymatic cleavage, and the polarity of the adenovirus type 2 fiber. Virology. 161:1987;121-128
13. Dion L.D., Goldsmith K.T., Tang D.C., Engler J.A., Yoshida M., Garver R.I. Jr. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase. Virology. 231:1997;201-209
14. Feigenblum D., Schneider R.J. Cap-binding protein (eukaryotic initiation factor 4E) and 4E-inactivating protein BP-1 independently regulate cap-dependent translation. Mol. Cell. Biol. 16:1996;5450-5457
15. Gaggar A., Shayakhmetov D.M., Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 9:2003;1408-1412
16. Harui A., Suzuki S., Kochanek S., Mitani K. Frequency and stability of chromosomal integration of adenovirus vectors. J. Virol. 73:1999;6141-6146
17. Kanerva A., Mikheeva G.V., Krasnykh V., Coolidge C.J., Lam J.T., Mahasreshti P.J., Barker S.D., Straughn M., Barnes M.N., Alvarez R.D., Hemminki A., Curiel D.T. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Clin. Cancer Res. 8:2002;275-280
18. Kim I.H., Jozkowicz A., Piedra P.A., Oka K., Chan L. Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc. Natl. Acad. Sci. U.S.A. 98:2001;13282-13287
19. Louis N., Fender P., Barge A., Kitts P., Chroboczek J. Cell-binding domain of adenovirus serotype 2 fiber. J. Virol. 68:1994;4104-4106
20. Mei Y.F., Lindman K., Wadell G. Two closely related adenovirus genome types with kidney or respiratory tract tropism differ in their binding to epithelial cells of various origins. Virology. 240:1998;254-266
21. Morral N., O'Neal W., Rice K., Leland M., Kaplan J., Piedra P.A., Zhou H., Parks R.J., Velji R., Aguilar-Cordova E., Wadsworth S., Graham F.L., Kochanek S., Carey K.D., Beaudet A.L. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. U.S.A. 96:1999;12816-12821
22. Morsy M.A., Caskey C.T. Expanded-capacity adenoviral vectors - The helper-dependent vectors. Mol. Med. Today. 5:1999;18-24
23. Morsy M.A., Gu M., Motzel S., Zhao J., Lin J., Su Q., Allen H., Franlin L., Parks R.J., Graham F.L., Kochanek S., Bett A.J., Caskey C.T. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc. Natl. Acad. Sci. U.S.A. 95:1998;7866-7871
24. Ng P., Parks R.J., Graham F.L. Preparation of helper-dependent adenoviral vectors. Methods Mol. Med. 69:2002;371-388
25. Oka K., Pastore L., Kim I.H., Merched A., Nomura S., Lee H.J., Merched-Sauvage M., Arden-Riley C., Lee B., Finegold M., Beaudet A., Chan L. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation. 103:2001;1274-1281
26. Pannell D., Ellis J. Silencing of gene expression: implications for design of retrovirus vectors. Rev. Med. Virol. 11:2001;205-217
27. Parks R.J., Graham F.L. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. J. Virol. 71:1997;3293-3298
28. Parks R.J., Chen L., Anton M., Sankar U., Rudnicki M.A., Graham F.L. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. U.S.A. 93:1996;13565-13570
29. Raper S.E., Yudkoff M., Chirmule N., Gao G.P., Nunes F., Haskal Z.J., Furth E.E., Propert K.J., Robinson M.B., Magosin S., Simoes H., Speicher L., Hughes J., Tazelaar J., Wivel N.A., Wilson J.M., Batshaw M.L. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum. Gene Ther. 13:2002;163-175
30. Roelvink P.W., Kovesdi I., Wickham T.J. Comparative analysis of adenovirus fiber-cell interaction: adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment. J. Virol. 70:1996;7614-7621
31. Rosenqvist N., Hard Af Segerstad C., Samuelsson C., Johansen J., Lundberg C. Activation of silenced transgene expression in neural precursor cell lines by inhibitors of histone deacetylation. J. Gene Med. 4:2002;248-257
32. Rossini M., Jonak G.J., Baserga R. Identification of adenovirus 2 early genes required for induction of cellular DNA synthesis in resting hamster cells. J. Virol. 38:1981;982-986
33. Ruigrok R.W., Barge A., Albiges-Rizo C., Dayan S. Structure of adenovirus fibre: II. Morphology of single fibres. J. Mol. Biol. 215:1990;589-596
34. Sato M., Suzuki S., Kubo S., Mitani K. Replication and packaging of helper-dependent adenoviral vectors. Gene Ther. 9:2002;472-476
35. Schoggins J.W., Gall J.G., Falck-Pedersen E. Subgroup B and f fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo. J. Virol. 77:2003;1039-1048
36. Segerman A., Arnberg N., Erikson A., Lindman K., Wadell G. There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses. J. Virol. 77:2003;1157-1162
37. Seya T., Hara T., Matsumoto M., Akedo H. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J. Immunol. 145:1990;238-245
38. Seya T., Hara T., Uenaka A., Nakayama E., Akedo H. Application of protein A-rosette assay for screening of monoclonal antibodies to human complement regulatory proteins. Complement Inflamm. 7:1990;78-89
39. Shayakhmetov D.M., Lieber A. Dependence of adenovirus infectivity on length of the fiber shaft domain. J. Virol. 74:2000;10274-10286
40. Shayakhmetov D.M., Papayannopoulou T., Stamatoyannopoulos G., Lieber A. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J. Virol. 74:2000;2567-2583
41. Stecher H., Shayakhmetov D.M., Stamatoyannopoulos G., Lieber A. A capsid-modified adenovirus vector devoid of all viral genes: assessment of transduction and toxicity in human hematopoietic cells. Mol. Ther. 4:2001;36-44
42. Steinwaerder D.S., Carlson C.A., Lieber A. DNA replication of first-generation adenovirus vectors in tumor cells. Hum. Gene Ther. 11:2000;1933-1948
43. Thomas C.E., Birkett D., Anozie I., Castro M.G., Lowenstein P.R. Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain. Mol. Ther. 3:2001;36-46
44. van Oostrum J., Burnett R.M. Molecular composition of the adenovirus type 2 virion. J. Virol. 56:1985;439-448
45. Yotnda P., Onishi H., Heslop H.E., Shayakhmetov D., Lieber A., Brenner M., Davis A. Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther. 8:2001;930-937
46. Zhang W.W., Alemany R., Wang J., Koch P.E., Ordonez N.G., Roth J.A. Safety evaluation of Ad5CMV-p53 in vitro and in vivo. Hum. Gene Ther. 6:1995;155-164